Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Imipenem with cilastin sodium |
Is a |
False |
Imipenem |
Inferred relationship |
Some |
|
Imipenem and cilastatin measurement |
Has measured component (attribute) |
False |
Imipenem |
Inferred relationship |
Some |
|
Imipenem measurement |
Has measured component (attribute) |
False |
Imipenem |
Inferred relationship |
Some |
|
Imipenem and cilastatin measurement |
Component |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Imipenem measurement |
Component |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Product containing cilastatin and imipenem (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Imipenem 500mg/cilastatin 500mg powder for infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Imipenem |
Inferred relationship |
Some |
|
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Imipenem |
Inferred relationship |
Some |
|
Imipenem 500mg/cilastatin 500mg powder for infusion solution transfer vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Imipenem |
Inferred relationship |
Some |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Imipenem |
Inferred relationship |
Some |
|
Imipenem 750mg/cilastatin 750mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Imipenem |
Inferred relationship |
Some |
|
Product containing imipenem (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Allergy to imipenem |
Causative agent (attribute) |
False |
Imipenem |
Inferred relationship |
Some |
|
Allergy to imipenem |
Causative agent (attribute) |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Cilastatin- and imipenem-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Imipenem monohydrate (substance) |
Is a |
False |
Imipenem |
Inferred relationship |
Some |
|
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Imipenem |
Inferred relationship |
Some |
2 |
Imipenem monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Imipenem |
Inferred relationship |
Some |
|
Cilastatin and imipenem only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Imipenem only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Product containing only cilastatin and imipenem in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Imipenem anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Imipenem |
Inferred relationship |
Some |
|
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Product containing cilastatin and imipenem and relebactam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Product containing only cilastatin and imipenem and relebactam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Product containing cilastatin and imipenem and relebactam in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Cilastatin and imipenem and relebactam only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Imipenem |
Inferred relationship |
Some |
1 |
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Imipenem |
Inferred relationship |
Some |
1 |
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Imipenem |
Inferred relationship |
Some |
1 |